---
title: "T4 EIA Kit, Cat No: BC-1007, Store at 2-8C, For in vitro diagnostic use only ... — FDA record Z-0214-2022 | Is It on Recall"
description: "Immunoassay TEST Kit do not meet product shelf-life standards resulting in failed controls."
url: https://isitonrecall.com/recall/fda-device-z-0214-2022-t4-eia-kit-cat-no-bc-1007-store-at-2-8c-for-in-vitro-diagnostic-use-only-this-product-s-intended-use/
updated: 2026-10-01
site: "Is It on Recall"
language: en
---

[Recall archive](https://isitonrecall.com/archives/) / FDA device enforcement

# T4 EIA Kit, Cat No: BC-1007, Store at 2-8C, For in vitro diagnostic use only This product s intended use is For the q... — FDA record Z-0214-2022

Reported terminated

Status as reported in the agency record. FDA warns that enforcement status may not track the current recall lifecycle; check the current official notice.

Source date Oct 14, 2021. Retrieved Oct 1, 2026. Last updated Oct 1, 2026.

Archive changed Oct 1, 2026. USDA FSIS records are unavailable; [check FSIS directly](https://www.fsis.usda.gov/recalls). [Source coverage and dates](https://isitonrecall.com/sources/).

## What the record says

- **Product**: T4 EIA Kit, Cat No: BC-1007, Store at 2-8C, For in vitro diagnostic use only This product s intended use is For the quantitative determination of total thyroxine (T4) concentration in human serum. The test is useful in the diagnosis and treatment of thyroid disorders.
- **Reason**: Immunoassay TEST Kit do not meet product shelf-life standards resulting in failed controls.
- **Classification**: Class II
- **Recalling firm**: BioCheck, Inc.
- **Quantity**: 314 kits
- **Agency-reported status**: Terminated
- **Source record identifier**: Z-0214-2022

[Open the official record](https://api.fda.gov/device/enforcement.json?search=recall_number%3A%22Z-0214-2022%22)

[What the recall classes mean](https://isitonrecall.com/guides/recall-classes/). Classification is an agency assessment, not individual medical advice.

## Lot and product identifiers

| Label field | Details supplied by the agency |
| --- | --- |
| Lot, code or applicability | Lot # RN-60831 or RN-60923 |

Match all identifying details in the current notice. A brand name alone is not enough.

## Distribution

US Distribution to states of: MI, FL, NJ, OH, CA; and OUS (foreign) distribution to countries of: Spain, Taiwan and Nigeria

States below are derived from the distribution text, including nationwide wording. They are not inferred from the firm's address.

- [California](https://isitonrecall.com/state/california/)
- [Florida](https://isitonrecall.com/state/florida/)
- [Michigan](https://isitonrecall.com/state/michigan/)
- [New Jersey](https://isitonrecall.com/state/new-jersey/)
- [Ohio](https://isitonrecall.com/state/ohio/)

## Dates in the source

- **Report date**: Nov 17, 2021
- **Recall initiation date**: Oct 14, 2021
- **Center classification date**: Nov 10, 2021
- **Termination date**: Feb 14, 2025

FDA company pages use the listing date; enforcement records use initiation dates; CPSC uses recall date; NHTSA uses report-received date. These dates are not interchangeable.

## What to do next

Read the official notice for the action that applies to your exact product.

[Read the current instructions](https://api.fda.gov/device/enforcement.json?search=recall_number%3A%22Z-0214-2022%22)

## Related records

[Medical devices records](https://isitonrecall.com/category/medical-devices/) [BioCheck, Inc. records](https://isitonrecall.com/brand/biocheck-inc/)